BNN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BRAIN Biotech AG

Watchlist Manager

Watchlist

Price: 2.83 EUR -2.41% Market Closed

Market Cap: €61.8m

	BRAIN Biotech AG XETRA:BNN	DE

Profitability Summary

BRAIN Biotech AG's profitability score is 16/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

57%

Gross Margin is Increasing

55% > 60%

Negative Operating Margin

-13%

Negative 3Y Average Operating Margin

-13%

Declining Operating Margin

-11% > -13%

Negative Net Margin

-23%

Negative 3Y Average Net Margin

-20%

Declining Net Margin

-12% > -23%

Negative Free Cash Flow Margin

-17%

Negative 3Y Average Free Cash Flow Margin

-12%

Declining Free Cash Flow Margin

-9% > -17%

Negative ROE

-1 030%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

Declining ROIC

-8% > -11%

View All

Hide

Collapse

16 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

57%

Gross Margin is Increasing

55% > 60%

Negative Operating Margin

-13%

Negative 3Y Average Operating Margin

-13%

Declining Operating Margin

-11% > -13%